Contribution of the C1A and C1B domains to the membrane interaction of protein kinase C

被引:47
作者
Giorgione, J
Hysell, M
Harvey, DF
Newton, AC [1 ]
机构
[1] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
关键词
D O I
10.1021/bi0350046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hallmark for protein kinase C activation is its "translocation" to membranes following generation of lipid second messengers. This translocation is mediated by the C1 and C2 domains, two membrane-targeting modules, whose engagement on membranes provides the energy for an activating conformational change in which an autoinhibitory pseudosubstrate sequence is released from the active site. Novel and conventional protein kinase C isozymes contain a tandem repeat of C1 domains, the CIA and C1B, which each contain a binding pocket for phorbol esters/diacylglycerol. This study addresses the contribution of the C1A and C1B domains in the regulation of protein kinase C's membrane interaction using bisfunctional (dimeric) phorbol myristate acetate (PMA) molecules. We show that dimeric bisphorbols are an order of magnitude more effective at recruiting full-length PKC betaII to membranes compared with monomeric PMA and that the effectiveness of the interaction depends on the nature and length of the cross-link between the PMA moieties. Most effective were dimeric phorbol 12-acetate 13-esters linked at the 13 position with a 14 carbon spacer. The increased potency of dimeric phorbol esters is reduced if either the CIA or C1B domains are mutated so that they are unable to bind PMA, if one moiety of the dimer contains a nonfunctional phorbol, or if the binding to the isolated C1B domain is measured. Thus, the increased potency of the dimeric phorbol esters results primarily from their ability to engage, to a limited extent, both C1 modules on the same molecule. Although dimeric phorbols were more potent than monomeric phorbol esters in recruiting protein kinase C to membranes, the magnitude of the increase was still several orders of magnitude lower than what would be predicted on the basis of the reduction in dimensionality that occurs when the first C1 domain is engaged on the membrane. Thus, engaging both domains can be forced but is highly unfavored. In summary, our data reveal that both C1 domains are oriented for potential membrane interaction but only one C1 domain binds ligand in a physiological context.
引用
收藏
页码:11194 / 11202
页数:9
相关论文
共 34 条
  • [1] Comparison of the roles of the C1a and C1b domains of protein kinase C alpha in ligand induced translocation in NIH 3T3 cells
    Bögi, K
    Lorenzo, PS
    Acs, P
    Szállási, Z
    Wagner, GS
    Blumberg, PM
    [J]. FEBS LETTERS, 1999, 456 (01) : 27 - 30
  • [2] Membrane targeting by C1 and C2 domains
    Cho, W
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) : 32407 - 32410
  • [3] DIMITRIJEVIC SM, 1995, MOL PHARMACOL, V48, P259
  • [4] HANNUN YA, 1986, J BIOL CHEM, V261, P9341
  • [5] SOLUTION STRUCTURE OF A CYSTEINE-RICH DOMAIN OF RAT PROTEIN-KINASE-C
    HOMMEL, U
    ZURINI, M
    LUYTEN, M
    [J]. NATURE STRUCTURAL BIOLOGY, 1994, 1 (06): : 383 - 387
  • [6] Cysteine-rich regions of protein kinase C delta are functionally non-equivalent - Differences between cysteine-rich regions of non-calcium-dependent protein kinase C delta and calcium-dependent protein kinase C gamma
    Hunn, M
    Quest, AFG
    [J]. FEBS LETTERS, 1997, 400 (02) : 226 - 232
  • [7] Signaling and subcellular targeting by membrane-binding domains
    Hurley, JH
    Misra, S
    [J]. ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2000, 29 : 49 - 79
  • [8] Hurley JH, 1997, PROTEIN SCI, V6, P477
  • [9] Subcellular targeting by membrane lipids
    Hurley, JH
    Meyer, T
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (02) : 146 - 152
  • [10] Comparison of chemical characteristics of the first and the second cysteine-rich domains of protein kinase C gamma
    Irie, K
    Yanai, Y
    Oie, K
    Ishizawa, J
    Nakagawa, Y
    Ohigashi, H
    Wender, PA
    Kikkawa, U
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (08) : 1725 - 1737